|
Real-time Estimate
Cboe BZX
13:07:09 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 17.91 USD | -0.83% |
|
-0.44% | +42.30% |
| 08-26 | U.S. research roundup- Intuit, MongoDB, Zscaler | RE |
| 08-13 | Amneal Pharmaceuticals Insider Sold Shares Worth $3,771,050, According to a Recent SEC Filing | MT |
| Market Cap | 6.29B 5.41B 5.08B 4.65B 8.67B 595B 8.74B 60.08B 23.4B 304B 23.62B 23.11B 979B | P/E 2026 * |
40.1x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 8.61B 7.41B 6.95B 6.36B 11.87B 814B 11.96B 82.22B 32.02B 416B 32.32B 31.62B 1,339B | EV / Sales 2026 * |
2.73x | EV / Sales 2027 * | 2.42x |
| Free-Float |
44.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMRX | Delayed | |
CBOE
| AMRX | Real-time | |
|
Deutsche Boerse AG
| 2DT | Delayed | |
|
Börse Stuttgart
| 2DT | Delayed | |
|
Tradegate
| 2DT | Real-time | |
|
Boerse Muenchen
| 2DT | Real-time |
Last Transcript : Amneal Pharmaceuticals, Inc.
| 1 day | -0.83% | ||
| 1 week | -0.44% | ||
| Current month | +2.63% | ||
| 1 month | -4.88% | ||
| 3 months | +39.26% | ||
| 6 months | +34.71% | ||
| Current year | +42.30% |
| 1 week | 17.18 |  | 18.32 |
| 1 month | 16.77 | | 19.15 |
| Current year | 11.71 | | 19.26 |
| 1 year | 9.32 | | 19.26 |
| 3 years | 3.36 | | 19.26 |
| 5 years | 1.24 | | 19.26 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Don | Executive/Senior Manager | -152,426 | 0.0477% | ||
| 8/13/26 | Sell | Director | -60,000 | 0.0188% | ||
| 8/12/26 | Sell | Head of Human Resources | -146,403 | 0.0458% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | -0.44% | +87.95% | +369.37% | 6.29B | |
| -0.12% | -1.57% | +56.89% | +107.39% | 1,034B | |
| +1.04% | +4.66% | +56.27% | +73.11% | 663B | |
| -0.35% | +1.04% | +23.12% | +78.54% | 462B | |
| +2.09% | -2.06% | +32.28% | +38.37% | 344B | |
| 0.00% | +5.36% | +27.40% | +47.50% | 307B | |
| +1.42% | +0.26% | -0.52% | +13.62% | 251B | |
| +0.14% | +1.56% | +56.35% | +74.72% | 239B | |
| -0.03% | +2.13% | -17.30% | -53.99% | 207B | |
| +0.21% | +0.92% | +32.96% | +99.88% | 186B | |
| Average | +0.50% | -0.59% | +35.54% | +84.85% | 369.97B | |
| Weighted average by Cap. | +0.54% | -0.84% | +38.60% | +68.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.15B 2.71B 2.55B 2.33B 4.35B 298B 4.38B 30.13B 11.73B 152B 11.84B 11.59B 491B | 3.43B 2.95B 2.77B 2.53B 4.73B 324B 4.77B 32.76B 12.76B 166B 12.88B 12.6B 534B |
| Net income | 149M 128M 120M 110M 205M 14.07B 207M 1.42B 554M 7.19B 559M 547M 23.15B | 295M 254M 238M 218M 406M 27.86B 410M 2.82B 1.1B 14.24B 1.11B 1.08B 45.86B |
| Net Debt | 2.32B 1.99B 1.87B 1.71B 3.2B 219B 3.22B 22.14B 8.62B 112B 8.7B 8.51B 361B | 2B 1.72B 1.61B 1.47B 2.75B 189B 2.77B 19.06B 7.42B 96.39B 7.49B 7.33B 310B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | US$17.93 | -0.72% | 496,065 |
| 26-09-02 | US$18.06 | +2.15% | 2,607,677 |
| 26-09-01 | US$17.68 | +1.20% | 1,364,822 |
| 26-08-31 | US$17.47 | -0.40% | 1,741,995 |
| 26-08-28 | US$17.54 | -2.61% | 1,151,922 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Select your edition
All financial news and data tailored to specific country editions
